Because it has been shown that the hyperactivated/exhausted CD8+ T-cell subset is enriched with tumor antigen–specific T cells, our data suggest that IL21 and anti-PD-1 in combination enhance the clonal expansion of the tumor antigen–specific CD8+ T cells. The gene discussed is CD8A; the disease is neoplasm.